Aliskiren hemifumarate is a direct renin inhibitor used in the treatment of essential hypertension by preventing the conversion of angiotensinogen to angiotensin I. This category provides an extensive… Read more


Aliskiren hemifumarate is a direct renin inhibitor used in the treatment of essential hypertension by preventing the conversion of angiotensinogen to angiotensin I. This category provides an extensive range of reference standards necessary for the precise analytical testing and quality control of this pharmaceutical agent. Included in the collection are diverse process-related impurities, degradation products, and various stereoisomers required for stringent method validation and comprehensive impurity profiling. These materials ensure that pharmaceutical laboratories can accurately identify and quantify secondary compounds throughout development and manufacturing. Furthermore, stable isotope labelled versions of the compound are available to support accurate quantification in pharmacokinetic and metabolic studies. This specialized inventory is designed to meet the rigorous demands of pharmaceutical research and regulatory compliance, providing the consistent quality required for reliable, reproducible analytical results.
